{"AllianceGenome": "16887", "HGNC": "16887", "MIM": "607178", "_id": "10158", "_version": 1, "accession": {"genomic": ["AL135960.1", "CH471059.2", "CP068277.2", "NC_000001.11", "NC_060925.1"], "protein": ["AAH12303.1", "CAB72104.1", "CAG29300.1", "EAX06878.1", "NP_005755.1", "Q13113.1"], "rna": ["BC012303.1", "BI763294.1", "BM924665.1", "CR450304.1", "NM_005764.4"], "translation": [{"protein": "AAH12303.1", "rna": "BC012303.1"}, {"protein": "NP_005755.1", "rna": "NM_005764.4"}, {"protein": "CAG29300.1", "rna": "CR450304.1"}]}, "alias": ["DD96", "MAP17", "SPAP"], "ensembl": {"gene": "ENSG00000162366", "protein": ["ENSP00000294338", "ENSP00000360952"], "transcript": ["ENST00000294338", "ENST00000371885", "ENST00000489919", "ENST00000491793"], "translation": [{"protein": "ENSP00000294338", "rna": "ENST00000294338"}, {"protein": "ENSP00000360952", "rna": "ENST00000371885"}], "type_of_gene": "protein_coding"}, "entrezgene": "10158", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 5.11463527754, "exp_mis": 40.1834316135, "exp_syn": 22.0397051532, "lof_z": 0.0502112058095537, "mis_z": -0.448807306625114, "mu_lof": 3.77482512989e-07, "mu_mis": 4.06220915892e-06, "mu_syn": 2.13984218008e-06, "n_lof": 5.0, "n_mis": 46.0, "n_syn": 24.0, "p_li": 0.000484064755406402, "p_null": 0.5612355274136, "p_rec": 0.438280407830993, "syn_z": -0.25886109803099}, "bp": 345, "cds_end": 47655604, "cds_start": 47649642, "n_exons": 4, "nonpsych": {"exp_lof": 4.56156407693, "exp_mis": 36.302209849, "exp_syn": 19.8803865706, "lof_z": -0.201604951963869, "mis_z": -0.476981559609362, "mu_lof": 3.77482512989e-07, "mu_mis": 4.06220915892e-06, "mu_syn": 2.13984218008e-06, "n_lof": 5.0, "n_mis": 42.0, "n_syn": 21.0, "p_li": 0.000376693796749056, "p_null": 0.633404396217081, "p_rec": 0.36621890998617, "syn_z": -0.158094885645766}, "nontcga": {"exp_lof": 4.69886811811, "exp_mis": 36.9621631552, "exp_syn": 20.2699340568, "lof_z": -0.137038103187191, "mis_z": -0.330887128359066, "mu_lof": 3.77482512989e-07, "mu_mis": 4.06220915892e-06, "mu_syn": 2.13984218008e-06, "n_lof": 5.0, "n_mis": 41.0, "n_syn": 24.0, "p_li": 0.000392664402704602, "p_null": 0.600856949765761, "p_rec": 0.398750385831534, "syn_z": -0.524581717192606}, "transcript": "ENST00000294338.2"}, "exons": [{"cdsend": 47189932, "cdsstart": 47183970, "chr": "1", "position": [[47183581, 47184043], [47185001, 47185097], [47187318, 47187427], [47189865, 47190036]], "strand": -1, "transcript": "NM_005764", "txend": 47190036, "txstart": 47183581}], "exons_hg19": [{"cdsend": 47655604, "cdsstart": 47649642, "chr": "1", "position": [[47649253, 47649715], [47650673, 47650769], [47652990, 47653099], [47655537, 47655708]], "strand": -1, "transcript": "NM_005764", "txend": 47655708, "txstart": 47649253}], "generif": [{"pubmed": 17230460, "text": "Large scale genetic screening identifies MAP17 as protein bypassing TNF-alpha-induced growth arrest."}, {"pubmed": 17426052, "text": "Independent activation of MAP17 promoter can be driven by oncogenes and might explain the common overexpression of MAP17 in human carcinomas."}, {"pubmed": 17548903, "text": "Tumorigenic capability of MAP17 through a connection between sodium-coupled co-transporters and reactive oxygen species."}, {"pubmed": 17675338, "text": "MAP17 protein activates AKT through ROS and this is determinant to confer resistance to Myc-induced apoptosis in the absence of serum."}, {"pubmed": 18303113, "text": "point mutation observed by transcriptome sequencing of malignant pleural mesothelioma tumors"}, {"pubmed": 19601982, "text": "The Th cell cytokine-induced up-regulation of MAP17 expression may be linked to the down-regulation of filaggrin in normal epidermal keratinocytes, which may be associated with abnormal epidermal differentiation observed in the dermatological diseases."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 22266858, "text": "MAP17 is overexpressed in late-stage breast tumors, in which oncogenic activity relies on p38 insensitivity to induce intracellular ROS."}, {"pubmed": 23418532, "text": "Results suggest that the use of MAP17 and SGLT1 markers may identify patients who are likely to exhibit a better response to treatments that boost oxidative stress in other cancer types."}, {"pubmed": 25788275, "text": "In this study we found that the levels of MAP17 were related to clinical findings and survival in a cohort of 58 patients with larynx cancer"}, {"pubmed": 25837675, "text": "Data show that bortezomib induces a prosurvival response through cytoprotective autophagy and nuclear factor kappa B (NFkappaB) nuclear translocation, which is repressed by high levels of membrane-associated protein 17 (MAP17)."}, {"pubmed": 27082702, "text": "Differential gene expression analysis demonstrated significant upregulation of PDZK1IP1, EEF1A2 and RPL41 (ENSG00000279483) genes in the intrahepatic cholangiocarcinoma samples when compared with the matched paratumor samples."}, {"pubmed": 27563810, "text": "We found that the levels of MAP17 were related to clinical features and poor survival in a cohort of 69 patients with different sarcoma types and suggest that MAP17 is a new biomarker to predict the efficacy of bortezomib as a new therapy for sarcomas."}, {"pubmed": 28153862, "text": "MAP17 overexpression activates Notch pathway by sequestering NUMB. High levels of MAP17 correlated with tumorsphere formation and Notch and Stem gene transcription. Its direct modification causes direct alteration of tumorsphere number and Notch and Stem pathway transcription"}, {"pubmed": 28592437, "text": "SGLT2/MAP17 functions as a low-affinity Na(+)-glucose cotransporter in the kidney."}, {"pubmed": 29650022, "text": "MAP17 is overexpressed in most carcinomas and in many tumors of mesenchymal origin, and correlates with higher grade and poorly differentiated tumors. This overexpression drives deep changes in cell homeostasis including increased oxidative stress, deregulation of signaling pathways and increased growth rates. Importantly, MAP17 is associated not only in cancer but in various inflammatory diseases. [review]"}, {"pubmed": 30119639, "text": "Our results indicate a potential prognostic role for MAP17 in lung tumours, with particular relevance in lung adenocarcinomas, and highlight the predictive pot0065ntial of this membrane-associated protein for platinum-based therapy and EGFR inhibitor efficacy. Furthermore, we propose bortezomib treatment as a novel and efficacious therapy for lung adenocarcinomas exhibiting high MAP17 expression."}, {"pubmed": 30156268, "text": "Membrane-associated protein 17 (MAP17) is shown to colocalize and coimmunoprecipitate with sodium/glucose cotransporter 2 (SGLT2)."}, {"pubmed": 30718277, "text": "These findings indicate that PDZK1IP1 interacts with Smad4 and thereby suppresses the TGF-beta signaling pathway."}, {"pubmed": 31273628, "text": "Combined expression of fascin-1 and MAP17 in breast cancer cells is associated with a significantly worse 5-year PFS, therefore recognizing a group of patients with high risk for early disease recurrence."}, {"pubmed": 32963243, "text": "Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment."}, {"pubmed": 33280497, "text": "MAP17 contributes to non-small cell lung cancer progression via suppressing miR-27a-3p expression and p38 signaling pathway."}, {"pubmed": 33832535, "text": "Hypoxia-dependent expression of MAP17 coordinates the Warburg effect to tumor growth in hepatocellular carcinoma."}, {"pubmed": 33853080, "text": "MAP17 Expression in Colorectal Cancer Is a Prognostic Factor for Disease Recurrence and Dismal Prognosis Already in Early Stage Disease."}, {"pubmed": 34719205, "text": "80MAP17 promotes the tumorigenesis of papillary thyroid carcinoma by reducing the stability of p53."}, {"pubmed": 35727731, "text": "PDZK1 Interacting Protein 1 Promotes the Progression of Papillary Thyroid Cancer."}, {"pubmed": 36737832, "text": "MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition."}], "genomic_pos": {"chr": "1", "end": 47191044, "ensemblgene": "ENSG00000162366", "start": 47183582, "strand": -1}, "genomic_pos_hg19": {"chr": "1", "end": 47656716, "start": 47649265, "strand": -1}, "go": {"CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0016020", "qualifier": "located_in", "term": "membrane"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 19056867, "qualifier": "located_in", "term": "extracellular exosome"}], "MF": {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [32296183, 32814053, 34880493, 38057552], "qualifier": "enables", "term": "protein binding"}}, "homologene": {"genes": [[9031, 424619], [9544, 709916], [9606, 10158], [9615, 475365], [9913, 613915], [10090, 67182], [10116, 81916]], "id": 4213}, "interpro": {"desc": "PDZK1-interacting protein 1/SMIM24", "id": "IPR031627", "short_desc": "PDZK1IP1/SMIM24"}, "ipi": "IPI00011858", "map_location": "1p33", "name": "PDZK1 interacting protein 1", "other_names": ["17 kDa membrane-associated protein", "PDZK1-interacting protein 1", "epithelial protein up-regulated in carcinoma, membrane associated protein 17", "membrane-associated protein 17"], "pantherdb": {"HGNC": "16887", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1914432", "ortholog_type": "LDO", "panther_family": "PTHR15296", "taxid": 10090, "uniprot_kb": "Q9CQH0"}, {"RGD": "620952", "ortholog_type": "LDO", "panther_family": "PTHR15296", "taxid": 10116, "uniprot_kb": "Q923S2"}, {"Ensembl": "ENSGALG00000010473", "ortholog_type": "LDO", "panther_family": "PTHR15296", "taxid": 9031, "uniprot_kb": "E1C111"}, {"ZFIN": "ZDB-GENE-081104-117", "ortholog_type": "O", "panther_family": "PTHR15296", "taxid": 7955, "uniprot_kb": "B0S4Z4"}, {"ZFIN": "ZDB-GENE-030616-128", "ortholog_type": "LDO", "panther_family": "PTHR15296", "taxid": 7955, "uniprot_kb": "Q1LXN4"}, {"Ensembl": "ENSDARG00000109919", "ortholog_type": "O", "panther_family": "PTHR15296", "taxid": 7955, "uniprot_kb": "A0A2R8QJT9"}], "uniprot_kb": "Q13113"}, "pdb": ["7VSI", "7WMV", "7YNI", "7YNJ", "7YNK", "8HB0", "8HDH", "8HEZ", "8HG7", "8HIN"], "pfam": "PF15807", "pharmgkb": "PA142671188", "pharos": {"target_id": 19173, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF169407", "relationship": "is"}, {"id": "GNF180313", "relationship": "is"}, {"id": "GNF191219", "relationship": "is"}, {"id": "GNF202125", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF008714", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF235821", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF112326", "relationship": "is"}, {"id": "GNF151967", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1"], "protein": "NP_005755.1", "rna": "NM_005764.4", "translation": {"protein": "NP_005755.1", "rna": "NM_005764.4"}}, "reporter": {"HG-U133_Plus_2": ["1553589_a_at", "219630_at"], "HG-U95Av2": "31610_at", "HTA-2_0": "TC01002627.hg.1", "HuEx-1_0": "2411173", "HuGene-1_1": "7915910", "HuGene-2_1": "16686774"}, "summary": "Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]", "symbol": "PDZK1IP1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1538615"}, "unigene": "Hs.431099", "uniprot": {"Swiss-Prot": "Q13113"}, "wikipedia": {"url_stub": "PDZK1IP1"}}